Elanco continues to restructure its business following its acquisition by Bayer Animal Health in 2019 for US$7.6 billion. The latest announcement details eliminating about 380 positions, including approximately 20 per cent of Elanco’s senior management. The company employs over 10,000 people world-wide. The company says it plans to realize “significant financial gains” through several major… Read More

Elanco Animal Health has received regulatory approval of its acquisition of Bayer Animal Health after agreeing to several anti-trust related conditions. The US$7.6 billion deal was announced in August 2019. As part of its review, Canada’s Competition Bureau found Elanco and Bayer Animal Health are each other’s closest competitors in several markets, specifically in poultry insecticides… Read More

Canadian sheep producers will now have access to Elanco Animal Health’s Flukiver (closantel) for the treatment of Haemonchus contortus (Barber Pole worm) in ewes and lambs. The oral anthelmintic was was only available through an Emergency Drug Release before now.   Haemonchus contortus is incredibly costly to the Canadian sheep industry. Of all the gastrointestinal nematodes (GIN) found… Read More